PCH
KURA icon

Polar Capital Holdings’s Kura Oncology KURA Stock Holding History

Polar Capital Holdings’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-350,000
Closed -$6.56K – 456
2021
Q3 		$6.56K Hold
350,000
– – 0.03% 263
2021
Q2 		$7.3K Hold
350,000
– – 0.03% 252
2021
Q1 		$9.89M Buy
350,000
+109,000
+45% +$3.45M 0.06% 208
2020
Q4 		$7.87M Buy
+241,000
New +$8.47M 0.05% 225

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Polar Capital Holdings's KURA Position: Q4 2021 in Review

Polar Capital Holdings sold out of Kura Oncology (KURA) in Q4 2021, closing a stake of 350,000 shares — an estimated $6.56K sold.

Polar Capital Holdings first reported a position in KURA in Q4 2020 and held it in 4 quarters. The position peaked at $9.89M in Q1 2021. 151 funds tracked by Wall St. Rank hold KURA as of Q4 2021.

  • Polar Capital Holdings reported no remaining Kura Oncology position as of Q4 2021 after selling out during the quarter.
  • Polar Capital Holdings sold 350,000 Kura Oncology shares in Q4 2021, an estimated $6.56K.
  • Polar Capital Holdings first reported a position in Kura Oncology in Q4 2020 and held it in 4 quarters.
  • Polar Capital Holdings's Kura Oncology position peaked at $9.89M in Q1 2021.
  • 151 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2021.

Based on Polar Capital Holdings's 13F filing for Q4 2021, filed 14 Feb 2022.